P/E ratio for Codexis (CDXS)
P/E ratio as of April 2024 (TTM): -3.29
According to Codexis 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -3.29412. At the end of 2022 the company had a P/E ratio of -9.14.
P/E ratio history for Codexis from 2010 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -9.14 | -90.07% |
| 2021 | -92.0 | 68.52% |
| 2020 | -54.6 | -28.33% |
| 2019 | -76.1 | 0.31% |
| 2018 | -75.9 | 354.55% |
| 2017 | -16.7 | -27.39% |
| 2016 | -23.0 | 3.31% |
| 2015 | -22.3 | 341.73% |
| 2014 | -5.04 | 288.8% |
| 2013 | -1.30 | -51.32% |
| 2012 | -2.66 | -76.89% |
| 2011 | -11.5 | -23.91% |
| 2010 | -15.1 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 14.1 | -528.75% | 🇺🇸 USA |
 Merck MRK | 69.7 | -2,216.37% | 🇺🇸 USA |
 Dupont De Nemours DD | 7.63 | -331.70% | 🇺🇸 USA |
 Balchem BCPC | 43.6 | -1,423.54% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.